Coreg and Inclusion body myositis - a phase IV clinical study of FDA data

Summary:

Inclusion body myositis is reported only by a few people who take Coreg.

The phase IV clinical study analyzes which people take Coreg and have Inclusion body myositis. It is created by eHealthMe based on reports of 46,057 people who have side effects while taking Coreg from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 14, 2023

46,057 people reported to have side effects when taking Coreg.
Among them, 4 people (0.01%) have Inclusion body myositis.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 47,443 Coreg users for its effectiveness, alternative drugs and more.

What is Inclusion body myositis?

Inclusion body myositis (inflammatory muscle disease, slowly progressive weakness and wasting) is found to be associated with 133 drugs and 72 conditions by eHealthMe.

Number of Coreg and Inclusion body myositis reports submitted per year:

Could Coreg cause Inclusion body myositis?

Gender of people who have Inclusion body myositis when taking Coreg *:

female: 0.0 %
male: 100 %

Age of people who have Inclusion body myositis when taking Coreg *:

Common drugs people take besides Coreg *:

Common side effects people have besides Inclusion body myositis *:

Pneumonia: 4 people, 100.00%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and have Inclusion body myositis?

Check whether Inclusion body myositis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

Related studies

How severe was Inclusion body myositis and when was it recovered:

Inclusion body myositis in Coreg

Expand to all the drugs that have ingredients of carvedilol:

Inclusion body myositis and drugs with ingredients of carvedilol (6 reports)

Alternative drugs to, pros and cons of Coreg:

Coreg (47,443 reports)

Common Coreg side effects:

Breathing difficulty: 3,867 reports
Fatigue (feeling of tiredness): 3,828 reports
Weakness: 3,259 reports
Dizziness: 3,208 reports
Hypotension (abnormally low blood pressure): 3,012 reports

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Inclusion body myositis treatments and more:

Inclusion body myositis (230 reports)

COVID vaccines that are related to Inclusion body myositis:

All the drugs that are associated with Inclusion body myositis:

Inclusion body myositis (133 drugs)

All the conditions that are associated with Inclusion body myositis:

Inclusion body myositis (72 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.